. Author manuscript; available in PMC: 2008 May 15.

Published in final edited form as: Eur J Med Genet. 2007 Nov 22;51(2):141–147. doi: 10.1016/j.ejmg.2007.11.001

Table 2.

Israeli male-breast-cancer (MBC) mutation testing results

		n tested	BRCA2 6174delT (%; 95%CI)	BRCA1 185delAG (%; 95%CI)	Total BRCA1/2 (%; 95%CI)
Jews		245	21 (8.6%; 5.4%-12.8%)	8 (3.3%; 1.4%-6.3%)	29 (11.8%; 8.1%-16.6%)
	Ashkenazi	188	17 (9.0%; 5.4%-14.1%)	7 (3.7%; 1.5%-7.5%)	24 (12.8%; 8.4%-18.4%)
	Non-Ashkenazi	55	4 (7.3%; 2.0%-17.6%)	1 (1.8%; ≤9.7%	5 (9.1%; 3.0%-20.0%)
	Undefined	2	0 (0%; ≤84.2%)	0 (0%; ≤84.2%)	0 (0%; ≤84.2%)
Arabs		16	0 (0%; ≤20.6%)	0 (0%; ≤20.6%)	0 (0%; ≤20.6%)

Total		261	21 (8.0%; 5.0%-12.0%)	8 (3.1%; 1.3%-5.9%)	29 (11.1%; 7.7%-15.4%)